News | Artificial Intelligence | October 26, 2022

Industry life sciences veteran to advance growth strategy and execution

Jieun Choe, chief marketing officer, Viz.ai. Source: Viz.ai

Jieun Choe, chief marketing officer, Viz.ai. Source: Viz.ai 

 


October 26, 2022 —  Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief marketing officer (CMO). Choe will report to CEO Chris Mansi, overseeing global marketing strategy, brand and communications, product marketing and demand generation. 

“Jieun’s deep experience and proven track record in driving growth with expert execution will be invaluable as we continue to expand our footprint worldwide,” said CEO Chris Mansi, M.D. “The addition of her customer-centric approach and strategic, growth mindset to our c-suite will help propel Viz.ai into new frontiers.” 

Choe was most recently chief strategy and marketing officer at Certara, a global leader in biosimulation, where she headed the global marketing team and drove the strategic planning process. Choe was also instrumental in helping lead the company to a successful IPO in December 2020. Earlier in her career, she worked in product management and strategy at Guidant and Boston Scientific, leading cross-functional teams and driving product strategy and launches. 

“I am thrilled to join Viz.ai as it embarks on its next stage of growth,” said Choe. “The company’s purpose-driven, diverse culture is impressive, empowering the Viz team to innovate outstanding solutions to improve patient outcomes and increase access to life-saving care. I look forward to working with the team to accelerate the momentum and fuel growth.” 

Choe received her Bachelors of Arts in Public Policy and Economics from Stanford University and a Masters of Business Administration from Stanford University’s Graduate School of Business

For more information: www.viz.ai 

Find more RSNA22 coverage here


Related Content

News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Ultrasound Imaging

Feb. 25, 2026 — GE HealthCare is introducing the next generation of LOGIQ general imaging ultrasound systems – an ...

Time February 25, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations with ...

Time February 20, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
Subscribe Now